Company Overview - NeuroPace, Inc. is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating debilitating seizures through its RNS System, which is the first and only commercially available brain-responsive platform that delivers personalized, real-time treatment at the seizure source [5] Leadership Change - Patrick F. Williams has been appointed as Chief Financial Officer, effective June 20, 2025, bringing over 25 years of financial and operational management experience in public medical device companies [2][3] - Rebecca Kuhn will depart from her CFO role but will remain in an advisory capacity for twelve months, having contributed significantly to the company over her 25-year tenure [2][3] Strategic Importance - The appointment of Mr. Williams is seen as timely, as the company is at a critical point in its growth trajectory and has significant opportunities for its RNS System [3] - Mr. Williams expressed excitement about joining NeuroPace, highlighting the potential to serve approximately 1.2 million U.S. patients living with drug-resistant epilepsy and the goal of making the RNS System the standard of care [4] Market Potential - The RNS System is positioned to expand access and utilization, with a commitment to product and data development aimed at improving patient outcomes [4]

Brings Proven Commercial Leadership, Reimbursement Expertise, and Global Market Insight to Support Next Phase of Growth Across Medical and Dental SegmentsROSELAND, N.J., May 19, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Shanth Thiyagalingam, BMedSc, MMKTG, MBA, has joined its Board of Directors, effective May 14, 2025. Mr. Thiyagalingam brings more than 20 y ...

Inspire Medical Systems (INSP) Q1 2025 Earnings Call May 05, 2025 05:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor RelationsTim Herbert - Chairman, President & CEORick Buchholz - CFOTravis Steed - Managing Director - Equity ResearchRichard Newitter - Managing DirectorChris Pasquale - Partner - Medical Devices & SuppliesAnthony Petrone - Managing DirectorJonathan Block - Managing DirectorBrett Gasaway - VP - Equity Research Conference Call Participants Danielle Antalffy - AnalystRober ...

Merit Medical Systems (MMSI) FDA Announcement January 28, 2025 04:30 PM ET Company Participants Fred Lampropoulos - Founder, CEO & ChairmanBrian Lloyd - Chief Legal Officer & Corporate SecretaryJohn Hall - Executive Vice President R&DDaniel Patel - Medical DirectorCaleb Konstanski - Vice President, Sales & Marketing - Renal TherapiesRaul Parra - CFO & TreasurerJayson Bedford - Managing Director, Equity ResearchWilliam Plovanic - Managing Director - Equity Research Conference Call Participants Jason Bednar - ...